Gene Synthesis & Protein Expression for COVID-19

Synbio Technologies’ Syno® DNA synthesis platform provides fast gene and fragment synthesis, high-throughput synthesis, metabolic pathways, gene assembly, etc. The independently developed CI sequence difficulty index system can facilitate the accurate, fast, and high-quality synthesis of any sequence.

Currently, we have completed the synthesis of all structural and non-structural protein genes or gene fragments of the COVID-19. This has promoted the acquisition of the virus recombinant proteins and the research of its protein structural biology. The virus-related target gene synthesis has been mass-produced, and can be delivered directly for research use only.

Competitive Advantages

  • Speed guarantee: All COVID-19 related orders will be given priority to green channel production, with 24/7 professional online support.
  • Quality assurance: ISO 13485 standards of manufacturing, high-quality raw materials, zero cross-contamination, and perfect track records.
  • Production capacity guarantee: Experienced synthesis experts, first in class instruments, more than one million probe kit materials supplied per day.

Proteins for COVID-19

ProteinExpression systemSizePrice ($)Availability
SARS-CoV-2 Spike S1 ProteinHuman 293 cells50 ug400Stock
SARS-CoV-2 Spike RBD ProteinHuman 293 cells50 ug400Stock
SARS-CoV-2 Spike S2 ProteinHuman 293 cells50 ug400Stock
SARS-CoV-2 Nucleocapsid ProteinHuman 293 cells50 ug400Stock
Recombinant Human ACE2 ProteinHuman 293 cells50 ug400Stock
Recombinant Human ACE2 Protein, with H374N, H378N mutationsHuman 293 cells50 ug400Stock
SARS-CoV-2 Spike full length with Fc tagHuman 293 cells1 mg5000Stock
SARS-CoV-2 Spike antibodyHuman 293 cells1 mg2000Stock
SARS-CoV-2 Nucleocapsid ProteinE.coli100 ug400Stock
SARS-CoV-2 Spike full lengthHuman 293 cells100 ug5501-2 weeks

* More discounts are available for a bulk orders (>1 mg), please contact us at service@synbio-tech.com

More COVID-19 DNA Solutions